Abstract
The paper presents a novel synthesis of AZT modified derivatives via click chemistry. Firstly, the reaction of 2,4-dihydroxyacetophenone (1) with propargyl bromide in acetone gave intermediates 2 in 75% yield. Next, new chalcones 3a-g were obtained in 55-65% yields through the Claisen-Schmidt reaction of 2 with different aromatic aldehydes. These chalcones were then oxidatively cyclized in DMSO in the presence of I2 to furnish new flavones 4a-g in 45-59% yields. Finally, title compounds 5a-g and 6a-g were obtained via click reaction of 3a-h and 4a-h with 3’-Azido-2’- deoxythymidine (AZT). Novel AZT derivatives 5a-g, 6a-g were evaluated for in vitro cytotoxic activity against five cell lines: MCF-7, SK-LU-1, SW480, HepG2 and P388. The result showed that most of AZT derivatives are active to five cell lines, in which compounds 5g and 5e are found to be the most potent cytotoxic activity against SK-LU-1 and P388 cell lines with IC50 value of 8.63 and 9.05 µg/mL, respectively.
Keywords: AZT, anti-cancer, Click chemistry, Chalcone, Flavone, Triazole.
Letters in Drug Design & Discovery
Title:Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity
Volume: 11 Issue: 3
Author(s): Nguyen Van Minh, Nguyen Le Anh, Do Thi Thao and Tran Khac Vu
Affiliation:
Keywords: AZT, anti-cancer, Click chemistry, Chalcone, Flavone, Triazole.
Abstract: The paper presents a novel synthesis of AZT modified derivatives via click chemistry. Firstly, the reaction of 2,4-dihydroxyacetophenone (1) with propargyl bromide in acetone gave intermediates 2 in 75% yield. Next, new chalcones 3a-g were obtained in 55-65% yields through the Claisen-Schmidt reaction of 2 with different aromatic aldehydes. These chalcones were then oxidatively cyclized in DMSO in the presence of I2 to furnish new flavones 4a-g in 45-59% yields. Finally, title compounds 5a-g and 6a-g were obtained via click reaction of 3a-h and 4a-h with 3’-Azido-2’- deoxythymidine (AZT). Novel AZT derivatives 5a-g, 6a-g were evaluated for in vitro cytotoxic activity against five cell lines: MCF-7, SK-LU-1, SW480, HepG2 and P388. The result showed that most of AZT derivatives are active to five cell lines, in which compounds 5g and 5e are found to be the most potent cytotoxic activity against SK-LU-1 and P388 cell lines with IC50 value of 8.63 and 9.05 µg/mL, respectively.
Export Options
About this article
Cite this article as:
Minh Van Nguyen, Anh Le Nguyen, Thao Thi Do and Vu Khac Tran, Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/157018081131000073
DOI https://dx.doi.org/10.2174/157018081131000073 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Green Reduction of Graphene Oxide into Graphene by Cow Urine
Current Nanomaterials Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders
Mini-Reviews in Medicinal Chemistry Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets The Inhibitory Effect of Cyclosporine A and Prednisolone on Both Cytotoxic CD8+ T Cells and CD4+CD25+ Regulatory T Cells
Current Signal Transduction Therapy Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease
Current Drug Targets Potential and Perspectives of Cyclonucleosides
Current Medicinal Chemistry Targeting Transcription Factors for Cancer Gene Therapy
Current Gene Therapy Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways
Anti-Cancer Agents in Medicinal Chemistry Ionic Liquids for Topical Delivery in Cancer
Current Medicinal Chemistry Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Current Cancer Drug Targets Yttrium-90 – Current Status, Expected Availability and Applications of a High Beta Energy Emitter
Current Radiopharmaceuticals Multi-Component Reactions Using Indium(III) Salts
Current Organic Chemistry Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies Across Caco-2 Cells
Current Drug Delivery History of Autoimmune Pancreatitis and Mikuliczs Disease
Current Immunology Reviews (Discontinued) Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
Anti-Cancer Agents in Medicinal Chemistry Enzyme-responsive Nanoparticles for Anticancer Drug Delivery
Current Nanoscience Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) Evaluation of BMP-2 Minicircle DNA for Enhanced Bone Engineering and Regeneration
Current Gene Therapy The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
Mini-Reviews in Medicinal Chemistry Dietary Phytochemicals in Chemoprevention of Cancer
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents